Skip to main content
Nature Communications logoLink to Nature Communications
. 2024 Jul 8;15:5723. doi: 10.1038/s41467-024-50151-0

Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Emma Copland 1, Martina Patone 1, Defne Saatci 1, Lahiru Handunnetthi 2,3, Jennifer Hirst 1, David P J Hunt 4, Nicholas L Mills 5,6, Paul Moss 7, Aziz Sheikh 1,6, Carol A C Coupland 1,8, Anthony Harnden 1, Chris Robertson 9, Julia Hippisley-Cox 1,
PMCID: PMC11231297  PMID: 38977699

Correction to: Nature Communications 10.1038/s41467-024-47745-z, published online 27 May 2024

The original version of this article contained information on vaccine dose amount (full or half) in Table 2 and Supplementary Table 1. This has subsequently been found to be inaccurate due to inconsistent coding in the raw data. The vaccine dose amount has therefore been removed from Table 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. An additional line has been added to the introduction to summarise vaccine doses that were given to the population:

“Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micrograms), and children aged 5–11 years were given a dose of 10 micrograms of BNT162b2 vaccine.”

These changes have been made in the PDF and HTML versions of the article.

Supplementary information

Supplementary Table 1 (2.4MB, pdf)

Supplementary information

The online version contains supplementary material available at 10.1038/s41467-024-50151-0.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table 1 (2.4MB, pdf)

Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES